📣 Discover today’s programme at #ICASA2025 — happening at Booth 50! We’re proud to highlight key moments of the day featuring the @medicinespatentpool.org team and partners. lnkd.in/e7DTMEYc #HIV #LongActing #GlobalHealth #AccessToMedicines #PublicHealth #EndingHIV #LeavingNoOneBehind

Yesterday, @who.int released its first-ever guideline on the use of GLP-1 therapies for adults living with obesity. This milestone follows the inclusion of GLP-1 medicines in the Essential Medicines List for managing type 2 diabetes in high-risk groups. 👉 www.who.int/news/item/01...

MPP and @unitaid.bsky.social are co-hosting “Breaking New Grounds: Long-Acting HIV Treatment for a New Generation”, at #ICASA2025. 📅 Wednesday 3 December 2025 | 11:45–12:30 GMT 📍 Room Prof. Souleymane Mboup & online Join us to discuss why long-acting HIV treatment matters. lnkd.in/e7DTMEYc

MPP joins @who.int @unaids.org @unitaid.bsky.social & partners to mark #WorldAIDSDay. Expanding access to dolutegravir-based regimens, paediatric formulations & long-acting therapeutics is vital for equity & choice. Through licensing, MPP helps make this possible. 🔗 shorturl.at/gEMKd

On #WorldAIDSDay, let's remember the role of #communities in driving the response, and how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍

On #WorldAIDSDay, meet Dorothy from #Kenya 🇰🇪, a young mother who turned fear into hope through community support and access to paediatric #HIV treatment like #pALD. Her story shows that progress is more than medicine—it’s about solidarity and dignity. 🔗 shorturl.at/6S1Qv #BetterMeds4Kids

💊 Every pack of #HIV treatment delivered through MPP licences means a life transformed. Ahead of #WorldAIDSDay, meet Hue from #Vietnam, mother, advocate & fighter. W/ improved treatment & community support, she turned stigma into strength and now helps others do the same. 🔗 bit.ly/43Vpbe6

🌍 Around the world, millions of people cannot access the medicines they need — not because the treatments don’t exist, but because they remain out of reach. At MPP, we work to change that. ✨ Join us: lnkd.in/eDizXjQb Watch the video: www.youtube.com/watch?v=3kqd... #LicensingSavesLives

MPP’s work in #licensing, #techtransfer and capacity-building aligns with Article 12’s benefit-sharing goals. We’ve long partnered with @who.int and Member States to turn these principles into access. 🤝🌍 👉 medicinespatentpool.org/news-publica...

MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪 Would you like to explore ways in which we could collaborate? 🤝 Get in touch: medicinespatentpool.org/licensingsav... #Sustainability #FundingHealthEquity

One tablet could change everything. The UNIVERSAL 1 trial is confirming the right dose for a single, dispersible DTG/FTC/TAF pill for children with #HIV, a formulation prioritised by GAP-f. Watch for more #BetterMeds4Kids #WorldChildrensDay #PaediatricHIV #EDCTP

On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines. Learn more: www.who.int/initiatives/... @pablorojo.bsky.social @sebmoringva.bsky.social

🦠 #RSV kills 100,000+ young children yearly, 97% in LMICs. Prevention works, but access to life-saving monoclonal antibodies is limited. On #WorldChildrensDay, let’s push for affordable RSV prevention so every child gets a healthy start. Learn more: bit.ly/4o0XGqo

💊 Honored to welcome @medicinespatentpool.org to visit community-based organizations in Hanoi, with the connection from ViiV Healthcare. Together, we shared how community-led HIV prevention and care are helping expand access to essential medicines and health services for all.

Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍

Our MPP team will be attending ICASA 2025 in Accra, Ghana 🇬🇭, just two weeks to go! Feel free to reach out to connect and explore new collaboration opportunities. Together, we can advance global health.🌍 #ICASA2025 #PublicHealth @sebmoringva.bsky.social

This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍 - #BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV

As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶 Together, we continue to advance paediatric HIV care! 🤝

On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind. 🔗 bit.ly/3WYVNzB

We're thrilled to welcome Mathieu Saint-Arnaud, Managing Director at Deutsche Bank, to the MPP's Governance Board! Mathieu’s expertise and global outlook will be invaluable as we advance MPP’s mission to improve access to #essential #medicines worldwide. 👉 medicinespatentpool.org/news-publica...

On #WorldPneumoniaDay, we spotlight #RSV — the leading cause of severe #pneumonia in infants. 100,000 child deaths yearly, 97% in LMICs. Prevention is critical, and access must improve. Read how MPP is driving change: medicinespatentpool.org/story-post/p... #BetterMeds4Kids

#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs. Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...

On #WorldPneumoniaDay, we share hope for the children battling severe pneumonia. The PediCAP-A trial showed that it's safe to switch children from IV to oral antibiotics sooner! ✅ Children go home sooner ✅ No more unnecessary IVs & long stays #PediCAP #ChildHealth #Pneumonia #GlobalHealth

Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact. Would you like to explore ways in which we could collaborate? 👉 medicinespatentpool.org/licensingsav... #FundingHealthEquity #GlobalHealth

With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth! #Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs. #AccessToMedicines #HealthEquity

At 🇹🇳 #AORTIC2025, our #allwomen panel challenged one of the most persistent misconceptions in access to immuno-oncology in Africa. ✨ Thanks to all the speakers shaping this discussion!

🌍 We’re hiring! The Medicines Patent Pool is looking for: - Programme Finance Officer 📅 Apply by: 31 October 2025 Learn more 👉 lnkd.in/eTYisnmb - Consultant / Firm – LAMP Technology Assessment 🗓 Apply by: 3 November 2025 Learn more 👉 lnkd.in/ejkr4nTi

🌏 Excited to share that Medicines Patent Pool was invited to the 5th Pharmaceutical Innovation Industry Conference 2025, in Shanghai! #PharmaInnovation #GlobalHealth #AccessToMedicines

🌍 MPP at #CPHIA2025 MPP is pleased to participate in this year’s #CPHIA2025, joining partners to discuss sustainable #localmanufacturing and equitable access to medical products across Africa. @eburrone.bsky.social - @tiwabraimoh.bsky.social

💊 The price of generic TLD (tenofovir, lamivudine, dolutegravir), the WHO-recommended HIV treatment, now costs under $37 per person per year, this has been a game changer in low- and middle-income countries.🌏 🤝 How we can collaborate together: medicinespatentpool.org/licensingsav...

Meaningful days in Accra for #AHMTEC2025! MPP’s Tiwadayo Braimoh and Meghmala Das joined a panel on #licensing opportunities for African manufacturing, showcasing how the MPP model supports access to essential health products and builds sustainable manufacturing capacity across #Africa.

🌍 We’re hiring! The Medicines Patent Pool is looking for a Programme Finance Officer to join our team in Geneva, Switzerland. 📅 Apply by: 31 October 2025 📧 Send your application to: [email protected] Learn more 👉 medicinespatentpool.org/call-for-app...

MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs. 👉 medicinespatentpool.org/story-post/m...

Children are too often left out of clinical trials. In Nature, our Head of HIV Justine Odionyi calls for drug development on neglected diseases to include children from the start. Read the piece (EN/FR): @nature.com #BeatNTDs #GlobalHealth www.nature.com/articles/d44...

At the UN High-Level Meeting on NCDs and Mental Health, MPP and partners convened a roundtable on expanding access to NCD medicines in LMICs. Together, we aim to turn commitments into action for equitable, affordable access. 🌍 medicinespatentpool.org/news-publica...

Voluntary #LicensingSavesLives by making medicines and health technologies affordable for low- and middle-income countries. 🌍 🤝 But we cannot achieve this great change without your help! 👉 medicinespatentpool.org/licensingsav...

Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign. Thank you to all colleagues for your energy, we look forward to what lies ahead!

Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib. Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social! lnkd.in/eruiP-Gv

🌍 MPP joined the Joint @who.int @unaids.org @unitaid.bsky.social annual consultation! Judith Federhofer shared updates on long-acting HIV treatment and the CAB-LA licence amendment for treatment + PrEP. @eburrone.bsky.social discussed access and pricing for #long-acting prevention in LMICs.

We’re proud to be recognized in the 2025 Global Health 50/50 Report as a high performer! MPP’s new Menstrual & Menopause Policy supports women’s health needs through flexible work, awareness & training. Read more: global5050.org/2025-report/

MPP welcomes the updated @who.int Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc). We remain committed to enabling #access to essential medicines through #voluntarylicensing, #technologytransfer, and #manufacturing support. 👉 lnkd.in/dmr98RHf

📢 MPP is looking for a new Expert Advisory Group (EAG) Member! 🗓️ Deadline to apply: 31 August 2025 📩 Apply by sending your CV and cover letter to [email protected] More info 👉 medicinespatentpool.org/who-we-are/c... #Vaccines #AccessToMedicines #PublicHealth #JobOpportunities

🌍 Join our mission 📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa
 📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.
 📢 Board Member Opportunity 👉 medicinespatentpool.org/who-we-are/c...

Taking HIV pills daily can be overwhelming. 💉 Long-acting injectables offer hope, safe and effective. LMICs still lack timely access. #Voluntarylicensing can change that, ensuring the most vulnerable benefit from innovation. 📖 www.sciencedirect.com/science/arti... 👉 www.youtube.com/watch?v=GGDM...

📢 Request for Proposal – GLP1-RA Market Assessment for Obesity Treatment 🗓 Deadline for submission: 7 September 2025 👉 To apply, send your proposal to [email protected] Full details here: medicinespatentpool.org/who-we-are/c...

🌟 Welcoming our new Expert Advisory Group members! We are delighted to welcome four new members to the @medicinespatentpool.org’s EAG. 🙏 A thank you to all our EAG members for their continued support and expertise in advancing MPP’s mission to increase #access to life-saving medicines 🌏.

🚨 We’re hiring! ⚖️ Associate Counsel 💉 Consultant: Feasibility & Concept Design Expert 👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c... #GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring

🌍 #WorldHepatitisDay2025 Charles Gore, founder of World Hepatitis Day, @worldhepalliance.bsky.social and MPP’s Executive Director, reminds us: 1.3M people die each year from viral hepatitis, and these deaths are preventable. 🔗 Full message: medicinespatentpool.org/news-publica...

🚨 We’re hiring! ⚖️ Associate Counsel 💉 Consultant: Feasibility & Concept Design Expert 👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c... #GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring

“We don’t have to explain ourselves all over again.” In Kigali, we visited HDI, led by Dr. Aflodis Kagaba, where sex workers, LGBTQ+ people & people who use drugs find stigma-free care, every day. ✍️ Read the full story: medicinespatentpool.org/story-post/b...